Antihemophilic Factor (Recombinant [Fc Fusion Protein]) and Quinapril
Determining the interaction of Antihemophilic Factor (Recombinant [Fc Fusion Protein]) and Quinapril and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Hemofil-M, Koate-DVI, Monoclate-P, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Jivi, Obizur
Synonyms: Antihemophilic factor (human), Antihemophilic Factor (Human)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Antihemophilic Factor (Recombinant [Fc Fusion Protein])-Quinapril and Hydrochlorothiazide
- Antihemophilic Factor (Recombinant [Fc Fusion Protein])-Quinapril Hydrochloride
- Antihemophilic Factor (Recombinant [Fc Fusion Protein])-Quinaretic
- Antihemophilic Factor (Recombinant [Fc Fusion Protein])-Quinidex Extentabs
- Antihemophilic Factor (Recombinant [Fc Fusion Protein])-Quinidine
- Antihemophilic Factor (Recombinant [Fc Fusion Protein])-Quinidine Controlled-Release Tablets
- Quinapril-Antihemophilic Factor (Recombinant [Pegylated-aucl])
- Quinapril-Antihemophilic Factor (Recombinant [Pegylated])
- Quinapril-Antihemophilic Factor (Recombinant [Pegylated]) Injection
- Quinapril-Antihemophilic Factor (Recombinant [Porcine Sequence])
- Quinapril-Antihemophilic Factor (Recombinant) (Advate)
- Quinapril-Antihemophilic Factor (Recombinant) (Afstyla)